5/20 #TumorBoardTuesday

💡Mini tweetorial 3.5

Can add darolutamide + ADT to the list w/ 📚ARANOTE trial
Pts: previously untreated met PCa
ADT vs ADT + darolutamide
Including both low and high burden of disease
Median PFS: 25.0 months w/o daro vs Not Reached w/ daro
#TumorBoardTuesday